摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Na-methoxycarbonyl-20-hydroxy-19-oxocatharanthine-20-d1 | 1313860-92-2

中文名称
——
中文别名
——
英文名称
Na-methoxycarbonyl-20-hydroxy-19-oxocatharanthine-20-d1
英文别名
dimethyl (1R,15R,18R)-17-(1-deuterio-1-hydroxyethyl)-14-oxo-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-pentaene-1,3-dicarboxylate
Na-methoxycarbonyl-20-hydroxy-19-oxocatharanthine-20-d1化学式
CAS
1313860-92-2
化学式
C23H24N2O6
mdl
——
分子量
425.445
InChiKey
ZQVWJAGAMYMFJL-HKONGNQISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    31
  • 可旋转键数:
    4
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    98.1
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Na-methoxycarbonyl-20-hydroxy-19-oxocatharanthine-20-d14-二甲氨基吡啶 、 sodium tetrahydroborate 、 四(三苯基膦)钯硼氘化钠三氟化硼乙醚potassium carbonate三乙胺 作用下, 以 四氢呋喃甲醇二氯甲烷 为溶剂, 反应 30.0h, 生成 catharanthine-20,20-d2
    参考文献:
    名称:
    On the Elucidation of the Mechanism ofVincaAlkaloid Fluorination in Superacidic Medium
    摘要:
    Detailed investigations on one of the key steps of the superacidic fluorination of Vinca alkaloids that is the origin of C20' activation are reported. While two different pathways can be envisioned for the emergence of the transient secondary carbocationic intermediate, isotopic labeling experiments unambiguously revealed the involvement of a 1,2-hydride shift mechanism.
    DOI:
    10.1021/ol201637m
  • 作为产物:
    描述:
    N-methoxycarbonylcatharanthine 在 manganese(IV) oxide 、 selenium(IV) oxide 、 硼氘化钠 、 cerium(III) chloride heptahydrate 、 、 sodium carbonate 作用下, 以 四氢呋喃甲醇乙醇二氯甲烷 为溶剂, 反应 93.0h, 生成 Na-methoxycarbonyl-20-hydroxy-19-oxocatharanthine-20-d1
    参考文献:
    名称:
    On the Elucidation of the Mechanism ofVincaAlkaloid Fluorination in Superacidic Medium
    摘要:
    Detailed investigations on one of the key steps of the superacidic fluorination of Vinca alkaloids that is the origin of C20' activation are reported. While two different pathways can be envisioned for the emergence of the transient secondary carbocationic intermediate, isotopic labeling experiments unambiguously revealed the involvement of a 1,2-hydride shift mechanism.
    DOI:
    10.1021/ol201637m
点击查看最新优质反应信息

文献信息

  • On the Elucidation of the Mechanism of<i>Vinca</i>Alkaloid Fluorination in Superacidic Medium
    作者:Emerson Giovanelli、Sébastien Leroux、Lionel Moisan、Hélène Carreyre、Pierre Thuéry、David-Alexandre Buisson、Abdelkrim Meddour、Jean-Marie Coustard、Sébastien Thibaudeau、Bernard Rousseau、Marc Nicolas、Paul Hellier、Eric Doris
    DOI:10.1021/ol201637m
    日期:2011.8.5
    Detailed investigations on one of the key steps of the superacidic fluorination of Vinca alkaloids that is the origin of C20' activation are reported. While two different pathways can be envisioned for the emergence of the transient secondary carbocationic intermediate, isotopic labeling experiments unambiguously revealed the involvement of a 1,2-hydride shift mechanism.
查看更多

同类化合物

马山茶碱 非洲伏康树碱 长春质碱 老刺木任 硫酸长春质碱 海尼山辣椒碱羟基假吲哚 榴花碱 柳黄酸 伏康京碱 伊菠胺-18-羧酸甲酯 伊菠胺 伊菠加因盐酸盐 伊博格碱 7-羟基-1-去氢老刺木碱 20-羟基榴花碱 14-((3alpha)-17-甲氧基-17-氧代派利文碱-3-基)-伊菠胺-18-羧酸甲酯 13-甲氧基-14-[(3A)-17-甲氧基-17-氧代派利文碱-3-基]-伊菠胺-18-羧酸甲酯 13-甲氧基-12-[(3a)-17-甲氧基-17-氧代派利文碱-3-基]-伊菠胺-18-羧酸甲酯 12-((3alpha)-17-甲氧基-17-氧代派利文碱-3-基)-伊菠胺-18-羧酸甲酯 11-羟基狗牙花定 10-羟基狗牙花定 (4a,20S)-20-羟基伊菠胺-18-羧酸甲酯 (2S)-1,2,3,4,4abeta,5,6,7,7a,12bbeta-十氢-4alpha-(1-羟基乙基)-9-甲氧基-2alpha,5alpha-甲桥吲哚并[3,2-d][1]苯并氮杂卓-7alpha-醇 epiibogaine N-methylcatharanthine quaternary salt lauryl albifloranine (+/-)-Coronaridine 18-methoxycoronaridine hydrochloride voacangine 19-Ethoxycoronaridin N-methylibogaine 2-(dimethylamino)ethyl (1R,15R,17S,18S)-17-ethyl-7-hydroxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxylate ethyl (1R,15R,17S,18S)-17-ethyl-7-hydroxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene-3-carboxylate [(1R,15R,17S,18S)-3-dimethoxyphosphoryl-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl] 4-methylpiperazine-1-carboxylate hydron;methyl (1S,15R,17S,18S)-17-ethyl-14-hydroxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate;chloride eglandine Ibogamine-18-carboxylic acid, 19-hydroxy-12-methoxy-, methyl ester, (19R)- 3-(beta-Hydroxyethyl)coronaridine Ibogamine-18-carboxylic acid, 13,20-dihydroxy-, methyl ester, (4alpha,20S)- 10-Hydroxyheyneanine Ibogamine-18-carboxylic acid, 21-hydroxy-, methyl ester Ibogamin-20-ol, 8,19-epoxy-12-methoxy-, (4alpha,8beta,19S,20S)- Voacangine Conopharyngine ibogaline (+/-)-coronaridine (-)-Ibogaine (15S,17R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene (15S,17R)-17-ethyl-7-methoxy-3-methyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene Voacangine 11-(3,4-dimethoxybenzyl)